X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (99) 99
oncology (83) 83
index medicus (73) 73
male (66) 66
female (65) 65
middle aged (58) 58
aged (54) 54
lung neoplasms - drug therapy (52) 52
lung neoplasms - pathology (41) 41
carcinoma, non-small-cell lung - drug therapy (39) 39
respiratory system (36) 36
adult (32) 32
neoplasm staging (31) 31
chemotherapy (30) 30
lung cancer (29) 29
article (27) 27
aged, 80 and over (26) 26
cancer (25) 25
carcinoma, non-small-cell lung - pathology (25) 25
lung neoplasms - genetics (25) 25
treatment outcome (25) 25
gefitinib (22) 22
lung neoplasms - mortality (20) 20
lung neoplasms - surgery (19) 19
antineoplastic combined chemotherapy protocols - therapeutic use (18) 18
prognosis (18) 18
tumors (17) 17
non-small cell lung cancer (16) 16
survival rate (16) 16
adenocarcinoma - drug therapy (15) 15
carcinoma, non-small-cell lung - mortality (15) 15
egfr (15) 15
lung cancer, non-small cell (15) 15
survival (15) 15
antineoplastic agents - therapeutic use (14) 14
carcinoma, non-small-cell lung - surgery (14) 14
erlotinib (14) 14
follow-up studies (14) 14
cell lung-cancer (13) 13
docetaxel (13) 13
adenocarcinoma - genetics (12) 12
adenocarcinoma - pathology (12) 12
carcinoma, non-small-cell lung - genetics (12) 12
lung neoplasms - diagnosis (12) 12
lung neoplasms - therapy (12) 12
mutation (12) 12
research (12) 12
united states (12) 12
chemotherapy, adjuvant (11) 11
receptor, epidermal growth factor - genetics (11) 11
retrospective studies (11) 11
erlotinib hydrochloride (10) 10
mutations (10) 10
paclitaxel (10) 10
proto-oncogene proteins - genetics (10) 10
quinazolines - administration & dosage (10) 10
surgery (10) 10
tomography, x-ray computed (10) 10
adenocarcinoma (9) 9
adjuvant chemotherapy (9) 9
animals (9) 9
care and treatment (9) 9
disease-free survival (9) 9
erbb receptors - genetics (9) 9
lung neoplasms - diagnostic imaging (9) 9
medicine & public health (9) 9
proto-oncogene proteins p21 (9) 9
pulmonary and respiratory medicine (9) 9
ras proteins - genetics (9) 9
tyrosine kinase inhibitor (9) 9
cancer research (8) 8
chemistry (8) 8
growth (8) 8
growth-factor receptor (8) 8
human necessities (8) 8
hygiene (8) 8
medical or veterinary science (8) 8
metallurgy (8) 8
mutation - genetics (8) 8
organic chemistry (8) 8
peptides (8) 8
preparations for medical, dental, or toilet purposes (8) 8
activation (7) 7
adenocarcinoma - mortality (7) 7
adenocarcinoma - surgery (7) 7
communication (7) 7
dna, neoplasm - genetics (7) 7
mice (7) 7
pharmacology & pharmacy (7) 7
prospective studies (7) 7
protein kinase inhibitors - therapeutic use (7) 7
resistance (7) 7
smoking (7) 7
survival analysis (7) 7
therapy (7) 7
trial (7) 7
abridged index medicus (6) 6
bevacizumab (6) 6
carcinoma (6) 6
carcinoma, squamous cell - drug therapy (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2013, 2nd ed., Jones & Bartlett learning Dx/Rx oncology series, ISBN 9781449600396, xv, 161
Book
The Journal of Thoracic and Cardiovascular Surgery, ISSN 0022-5223, 09/2019
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2016, Volume 11, Issue 1, p. e0146063
Background Lung cancers account for the majority of brain metastases which pose major therapeutic challenges. Biomarkers prognosticating for the development of... 
CYFRA-21-1 | SURVIVAL | DIAGNOSIS | SCC | TUMOR-MARKERS | PROGNOSTIC-FACTORS | EGFR MUTATION STATUS | MULTIDISCIPLINARY SCIENCES | CARCINOEMBRYONIC ANTIGEN | CARCINOMA | RADIATION-THERAPY | Outcome Assessment (Health Care) - methods | Predictive Value of Tests | Prognosis | Prospective Studies | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Brain Neoplasms - secondary | Phosphopyruvate Hydratase - blood | Sensitivity and Specificity | Antigens, Neoplasm - blood | Brain Neoplasms - blood | Keratin-19 - blood | Peptide Fragments - blood | Aged, 80 and over | Adult | Female | Tissue Inhibitor of Metalloproteinase-1 - blood | Carcinoma, Non-Small-Cell Lung - pathology | Enzyme-Linked Immunosorbent Assay | Brain Neoplasms - diagnosis | Biomarkers, Tumor - blood | Recombinant Proteins - blood | Proteins - metabolism | Proteomics | Carcinoma, Non-Small-Cell Lung - blood | Aged | Lung Neoplasms - blood | Serpins - blood | Neoplasm Staging | Complications and side effects | Care and treatment | Usage | Metastasis | Research | Lung cancer, Non-small cell | Biological markers | Risk factors | Brain | Laboratories | Toxicity | Lung cancer | Oncology | Biology | Tissue inhibitor of metalloproteinase 1 | Epidemiology | Cancer therapies | Metastases | Incidence | Epidermal growth factor | Bioindicators | Pretreatment | Enzyme-linked immunosorbent assay | Medical research | Antigens | Enzymes | Statistical analysis | Epidermal growth factor receptors | Non-small cell lung carcinoma | Histology | Regression analysis | Patients | Medicine | Chemotherapy | Brain research | Lungs | Biomarkers | Mutation
Journal Article
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2016, Volume 22, Issue 18, pp. 4585 - 4593
Journal Article